Skip to Content
Merck
  • Leptin downregulates aggrecan through the p38-ADAMST pathway in human nucleus pulposus cells.

Leptin downregulates aggrecan through the p38-ADAMST pathway in human nucleus pulposus cells.

PloS one (2014-10-10)
Zheng Li, Xin Yu, Jinqian Liang, William Ka Kei Wu, Jun Yu, Jianxiong Shen
ABSTRACT

The mechanistic basis of obesity-associated intervertebral disc degeneration (IDD) is unclear. Aberrant expression of aggrecan and its degrading enzymes ADAMTS-4 and ADAMTS-5 is implicated in the development of IDD. Here, we investigated the effect of leptin, a hormone with increased circulating levels in obesity, on the expression of aggrecan and ADAMTSs in primary human nucleus pulposus (NP) cells. Real-time PCR and Western blots showed that leptin increased the mRNA and protein expression of ADAMTS-4 and ADAMTS-5 and reduced the level of aggrecan in NP cells, accompanied by a prominent induction of p38 phosphorylation. Treatment of NP cells with SB203580 (a p38 inhibitor) abolished the regulation of aggrecan and ADAMTSs by leptin. Knockdown of ADAMTS-4 and ADAMTS-5 by siRNAs also attenuated the degradation of aggrecan in leptin-stimulated NP cells. To conclude, we demonstrated that leptin induces p38 to upregulate ADAMTSs and thereby promoting aggrecan degradation in human NP cells. These results provide a novel mechanistic insight into the molecular pathogenesis of obesity-associated IDD.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human ADAMTS5
Sigma-Aldrich
MISSION® esiRNA, targeting human ADAMTS3
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Adamts3
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Adamts4
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Adamts5